Literature DB >> 23622814

Mycobacterial lineages causing pulmonary and extrapulmonary tuberculosis, Ethiopia.

Rebuma Firdessa1, Stefan Berg, Elena Hailu, Esther Schelling, Balako Gumi, Girume Erenso, Endalamaw Gadisa, Teklu Kiros, Meseret Habtamu, Jemal Hussein, Jakob Zinsstag, Brian D Robertson, Gobena Ameni, Amanda J Lohan, Brendan Loftus, Iñaki Comas, Sebastien Gagneux, Rea Tschopp, Lawrence Yamuah, Glyn Hewinson, Stephen V Gordon, Douglas B Young, Abraham Aseffa.   

Abstract

Molecular typing of 964 specimens from patients in Ethiopia with lymph node or pulmonary tuberculosis showed a similar distribution of Mycobacterium tuberculosis strains between the 2 disease manifestations and a minimal role for M. bovis. We report a novel phylogenetic lineage of M. tuberculosis strongly associated with the Horn of Africa.

Entities:  

Keywords:  Ethiopia; Mycobacterium bovis; Mycobacterium tuberculosis; TB lymphadenitis; Tuberculosis and other mycobacteria; bacteria; bovine; cervical lymph nodes; extrapulmonary tuberculosis; lineage; lymph nodes; pulmonary tuberculosis; tuberculosis; zoonoses; zoonotic transmission

Mesh:

Year:  2013        PMID: 23622814      PMCID: PMC3647644          DOI: 10.3201/eid1903.120256

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Ethiopia is among the countries with the highest incidence of tuberculosis (TB) and has a yearly incidence of 261 cases/100,000 population. TB lymphadenitis in cervical lymph nodes (TBLN) accounts for ≈33% of all new cases in this country, which is greater than the global average of ≈15% (). Ethiopia has the largest livestock population in Africa (≈51 million cattle), and recent studies have shown that bovine TB is endemic in this country (estimated prevalence 1%–10%) (). To explore the public health risk for bovine TB in Ethiopia, we have used molecular typing to characterize mycobacterial isolates from persons with TBLN and pulmonary TB who were visiting hospitals throughout the country. Our aim was to define the role of Mycobacterium bovis in human TB and to define the overall structure of the M. tuberculosis complex in Ethiopia.

The Study

Patients with suspected TBLN or pulmonary TB who came to hospitals or health centers in study sites and provided voluntary consent were recruited into the study during 2006–2010. Fine needle–aspirate samples and sputum samples were collected from 2,151 patients attending hospitals in Gondar, Woldiya, Ghimbi, Butajira, and Negelle, Ethiopia. In addition, sputum samples were collected from patients at hospitals in Fiche, Jinka, and Filtu and at health centers at 3 suburban sites in Addis Ababa (Holeta, Sululta, and Chancho). Samples were cultured on Löwenstein-Jensen medium supplemented with glycerol or pyruvate and on modified Middlebrook 7H11 medium optimized for culture of M. bovis. We characterized isolates belonging to the M. tuberculosis complex by using multiplex PCR for large sequence polymorphisms (,), spoligotyping (), and lineage-specific single-nucleotide polymorphism analysis (,). Isolates of selected spoligotypes were characterized by 24-loci mycobacterial interspersed repetitive unit–variable number tandem repeat (MIRU-VNTR) analysis (). Four M. tuberculosis isolates from a group of 36 with unusual spoligotype patterns were further characterized by genome sequencing (Illumina Inc., San Diego, CA, USA). Sequencing reads were mapped to the inferred most recent common ancestor of the M. tuberculosis complex (). A final alignment of 13,199 single-nucleotide polymorphism positions was generated and analyzed by using the neighbor-joining method with a Tamura-Nei evolutionary model (www.megasoftware.net/mega_papers.php). Nontuberculous mycobacteria were characterized by sequencing of the 16S rDNA gene. Characteristics of 964 cultures positive for acid-fast bacilli are summarized in Table 1. Most of these isolates had an intact RD9 region, which identified them as M. tuberculosis. Only 4 (0.4%) of 964 isolates had undergone RD9 and RD4 deletions characteristic of M. bovis (). The 4 M. bovis isolates were obtained from cases of pulmonary TB, 3 of which were from patients living in pastoralist communities in southern Ethiopia. The 10 nontuberculous mycobacterial isolates were identified as M. intracellulare, M. flavescens, and M. simiae; 2 of the isolates were from patients co-infected with M. tuberculosis.
Table 1

Mycobacterium spp. and strains, Ethiopia, 2006–2010*

Collection sitePulmonary TB
TBLN
M. tuberculosis
M. bovis NTMM. tuberculosis
M. bovis NTM
TotalL4L3L7L1TotalL4L3L7L1
Gondar92325820003221110000
Woldiya239104000110544313005
Ghimbi4740610006958110000
Fiche‡169128356010NANANANANANANA
Addis Ababa‡605073000NANANANANANANA
Butajira70609100011091136000
Negelle/Filtu/Jinka16112328010337510102
Total isolates6224421531710433282297919107
Total M. tuberculosis %10071.124.62.71.6NANA10069.824.15.80.3NANA

*Values are no. isolates. TB, tuberculosis; TBLN, TB lymphadenitis in cervical lymph nodes; NTM, nontuberculous mycobacteria; NA, not applicable.
†Lineage of M. tuberculosis is expressed by an L followed by a digit.
‡TBLN samples were not collected in Fiche and Addis Ababa.

*Values are no. isolates. TB, tuberculosis; TBLN, TB lymphadenitis in cervical lymph nodes; NTM, nontuberculous mycobacteria; NA, not applicable.
†Lineage of M. tuberculosis is expressed by an L followed by a digit.
‡TBLN samples were not collected in Fiche and Addis Ababa. Among the 954 isolates belonging to the M. tuberculosis complex, 671 (71%) belonged to lineage 4, which was the most common lineage in Ethiopia. However, lineage 3 was most prevalent in the northern sites of Gondar and Woldiya (122/257, 47%). Eleven strains belonging to lineage 1 were isolated in the southern region. Two isolates with a characteristic Beijing family spoligotype (spoligotype international type [SIT] 1) were identified as pseudo-Beijing strains belonging to lineage 3 (). Thirty-six isolates with an unusual spoligotype pattern (missing spacers 4–24) and intact for the TbD1 region could not be assigned to known lineages. Genome sequencing identified these strains as members of a new lineage (lineage 7) localized between ancient lineage 1 and modern lineages 2, 3, and 4 of M. tuberculosis phylogeny (Figure 1). This new lineage 7 was prominent among strains collected in the Woldiya region (17/133 strains, 13%) (Table 1).
Figure 1

Lineages of the Mycobacterium tuberculosis (MTB) complex, Ethiopia, 2006–2010. Genome sequence analysis of 4 strains representative of 36 related isolates identified them as members of a new phylogenetic lineage (lineage 7) of M. tuberculosis, which has a phylogenetic location intermediate between ancient lineage 1 and modern Lineages 2, 3, and 4, and a branch point before the deletion of the TbD1 region (). Nomenclatures for lineage names and numbers are as proposed (,). Phylogeny shown is based on 13,199 nt positions that were variable in at least 1 of the 28 M. tuberculosis complex strains represented in the tree. Numbers near nodes indicate percentage of bootstrap replicates supporting the topology after 1,000 pseudoreplicates. MAF, M. africanum; MBO, M. bovis.

Lineages of the Mycobacterium tuberculosis (MTB) complex, Ethiopia, 2006–2010. Genome sequence analysis of 4 strains representative of 36 related isolates identified them as members of a new phylogenetic lineage (lineage 7) of M. tuberculosis, which has a phylogenetic location intermediate between ancient lineage 1 and modern Lineages 2, 3, and 4, and a branch point before the deletion of the TbD1 region (). Nomenclatures for lineage names and numbers are as proposed (,). Phylogeny shown is based on 13,199 nt positions that were variable in at least 1 of the 28 M. tuberculosis complex strains represented in the tree. Numbers near nodes indicate percentage of bootstrap replicates supporting the topology after 1,000 pseudoreplicates. MAF, M. africanum; MBO, M. bovis. Lineage distribution was identical between the 2 disease forms at the national level; lineage 4 was isolated from 71% (442/662) and 70% (229/328) of pulmonary TB and TBLN patients, respectively, and lineage 3 was isolated from 25% (153/622) and 24% (79/328), respectively. The M. tuberculosis isolates encompassed 176 spoligotypes (Technical Appendix Table 1), of which 86 patterns were new to the international genotyping database 2 (SITVIT2) (www.pasteur-guadeloupe.fr:8081/SITVITDemo/) (). A total of 11% (101/950) of the isolates represented single spoligotypes, and 62% (591/950) were included in 10 major spoligotype clusters (Table 2).
Table 2

Major spoligotype clusters of Mycobacterium tuberculosis, Ethiopia, 2006–2010*

SIT no.SITVIT2LineageNo. isolates from each site
Disease
GoWoGiFiAABuNFJPTBTBLN
149T3-ETH491734815203812525
25CAS1338321118313107748
53T147101710832145840
37T342223879103922
3134New4113423302618
26CAS137328444257
21CAS135213007162
41LAM7-TUR43035006125
1729Undesignated701303010512
4LAM341302019115
910Undesignated71312340104

*SIT, spoligotype international type; SITVIT2, SIT international genotyping database 2; Go, Gondar; Wo, Woldiya; Gi, Ghimbi; Fi, Fiche; AA, Addis Ababa; Bu, Butajira; NFJ, Negelle, Filtu, and Jinka; PTB, pulmonary TB; TBLN, TB lymphadenitis in cervical lymph nodes.

*SIT, spoligotype international type; SITVIT2, SIT international genotyping database 2; Go, Gondar; Wo, Woldiya; Gi, Ghimbi; Fi, Fiche; AA, Addis Ababa; Bu, Butajira; NFJ, Negelle, Filtu, and Jinka; PTB, pulmonary TB; TBLN, TB lymphadenitis in cervical lymph nodes. There was no difference in cluster distribution between pulmonary TB and lymph node TB isolates; 10% and 11%, respectively, were single types, and 64% and 60%, respectively, were included in dominant clusters. Two large clusters representative of lineage 4 (SIT 149) and lineage 3 (SIT 25) were further characterized by MIRU-VNTR typing (Technical Appendix Table 2) and network analysis (Figure 2). In each case, TBLN and pulmonary TB samples were dispersed throughout the network of spoligotype clusters.
Figure 2

Mycobacterial interspersed repetitive unit–variable number tandem repeat (MIRU-VNTR) networks of major spoligotype clusters, Ethiopia, 2006–2010. Two large spoligotype clusters from lineage 4 (A) (90 isolates of sopligotype 149) and lineage 3 (B) (73 isolates of spoligotype 25) were further characterized by 24-loci MIRU-VNTR typing (Technical Appendix Table 2). Minimum-spanning trees were calculated for each cluster by using MIRU-VNTRplus (www.miru-vntrplus.org). Each circle indicates an individual genotype. Genotypes L and E1 include >15 isolates and remaining genotypes include <15 isolates. Genotypes indicated by a black circle were isolated from patients with pulmonary tuberculosis (TB); those in light gray were isolated from patients with TB lymphadenitis in cervical lymph nodes (TBLN); and those in dashed circles were isolated from patients with pulmonary TB and those with TBLN. Numbers on lines between circles indicate distance between 2 genotypes.

Mycobacterial interspersed repetitive unit–variable number tandem repeat (MIRU-VNTR) networks of major spoligotype clusters, Ethiopia, 2006–2010. Two large spoligotype clusters from lineage 4 (A) (90 isolates of sopligotype 149) and lineage 3 (B) (73 isolates of spoligotype 25) were further characterized by 24-loci MIRU-VNTR typing (Technical Appendix Table 2). Minimum-spanning trees were calculated for each cluster by using MIRU-VNTRplus (www.miru-vntrplus.org). Each circle indicates an individual genotype. Genotypes L and E1 include >15 isolates and remaining genotypes include <15 isolates. Genotypes indicated by a black circle were isolated from patients with pulmonary tuberculosis (TB); those in light gray were isolated from patients with TB lymphadenitis in cervical lymph nodes (TBLN); and those in dashed circles were isolated from patients with pulmonary TB and those with TBLN. Numbers on lines between circles indicate distance between 2 genotypes. All 4 M. bovis isolates from humans showed typical bovine spoligotype profiles lacking spacers 3, 9, 16, and 39–43. In addition, they lacked spacers 4–7 and had deletions of RDAf2, which are features that define strains of the African 2 clonal complex of M. bovis reported from TB-infected cattle in Ethiopia ().

Conclusions

The frequency of M. bovis in persons in this study (0.4%) is similar to that found in other studies of human TB in Africa () and South and Central America (), but much lower than that observed among selected populations in Tanzania (16%) (), Ethiopia (17%) (), and Mexico (28%) (). These findings indicate that the overall contribution of M. bovis to human TB is minor but greater in specific areas. In Ethiopia, monitoring of zoonotic transmission is needed in urban areas with high rates of bovine TB associated with intensive farming of imported dairy cattle (R. Firdessa et al., unpub. data) and among pastoralist populations from which human M. bovis cases were identified in this study. Zoonotic transmission of M. bovis can be excluded as the predominant cause of the high national incidence of TBLN in Ethiopia. Mapping of disease networks by spoligotyping and MIRU-VNTR analysis showed an integrated distribution of the 2 disease forms, which suggested that cases of TBLN arise from within the pulmonary TB transmission network, rather than from an external zoonotic source. We identified a novel phylogenetic lineage of M. tuberculosis (lineage 7) in multiple sites and at a high frequency in Woldiya in the northeastern highlands of Ethiopia. Screening of the SITVIT2 database () and the US Centers for Disease Control and Prevention National Tuberculosis Genotyping Surveillance Network Database (L.S. Cowan, pers. comm.) identified 23 (0.03%) of ≈90,000 isolates as members of lineage 7; all were isolated from patients whose country of origin (when known) was in the Horn of Africa. Lineage 7 is of considerable evolutionary interest because it represents a phylogenetic branch intermediate between the ancient and modern lineages of M. tuberculosis (,,).

Technical Appendix

Strain frequencies of respective spoligotype international types (SITs) of Mycobacterium tuberculosis isolated in this study, results of large and small sequence polymorphism typing, and typing results of 24-loci mycobacterial interspersed repetitive unit–variable number tandem repeats for isolates of spoligotypes SIT 25 and SIT 149, Ethiopia, 2006–2010.
  14 in total

1.  Molecular identification of Mycobacterium bovis and the importance of zoonotic tuberculosis in Mexican patients.

Authors:  L Portillo-Gómez; E G Sosa-Iglesias
Journal:  Int J Tuberc Lung Dis       Date:  2011-10       Impact factor: 2.373

2.  African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East Africa.

Authors:  Stefan Berg; M Carmen Garcia-Pelayo; Borna Müller; Elena Hailu; Benon Asiimwe; Kristin Kremer; James Dale; M Beatrice Boniotti; Sabrina Rodriguez; Markus Hilty; Leen Rigouts; Rebuma Firdessa; Adelina Machado; Custodia Mucavele; Bongo Nare Richard Ngandolo; Judith Bruchfeld; Laura Boschiroli; Annélle Müller; Naima Sahraoui; Maria Pacciarini; Simeon Cadmus; Moses Joloba; Dick van Soolingen; Anita L Michel; Berit Djønne; Alicia Aranaz; Jakob Zinsstag; Paul van Helden; Françoise Portaels; Rudovick Kazwala; Gunilla Källenius; R Glyn Hewinson; Abraham Aseffa; Stephen V Gordon; Noel H Smith
Journal:  J Bacteriol       Date:  2010-11-19       Impact factor: 3.490

3.  Identification of the causative organism of tuberculous lymphadenitis in ethiopia by PCR.

Authors:  Dawit Kidane; Joseph O Olobo; Abebe Habte; Yohannes Negesse; Abraham Aseffa; Getahun Abate; Mohammed A Yassin; Kiflu Bereda; Morten Harboe
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Isolation of Mycobacterium bovis from human cases of cervical adenitis in Tanzania: a cause for concern?

Authors:  R R Kazwala; C J Daborn; J M Sharp; D M Kambarage; S F Jiwa; N A Mbembati
Journal:  Int J Tuberc Lung Dis       Date:  2001-01       Impact factor: 2.373

5.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

6.  A new evolutionary scenario for the Mycobacterium tuberculosis complex.

Authors:  R Brosch; S V Gordon; M Marmiesse; P Brodin; C Buchrieser; K Eiglmeier; T Garnier; C Gutierrez; G Hewinson; K Kremer; L M Parsons; A S Pym; S Samper; D van Soolingen; S T Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

7.  Three-year population-based evaluation of standardized mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing of Mycobacterium tuberculosis.

Authors:  Caroline Allix-Béguec; Maryse Fauville-Dufaux; Philip Supply
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

8.  The Guinea-Bissau family of Mycobacterium tuberculosis complex revisited.

Authors:  Ramona Groenheit; Solomon Ghebremichael; Jenny Svensson; Paulo Rabna; Raffaella Colombatti; Fabio Riccardi; David Couvin; Véronique Hill; Nalin Rastogi; Tuija Koivula; Gunilla Källenius
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

9.  "Pseudo-Beijing": evidence for convergent evolution in the direct repeat region of Mycobacterium tuberculosis.

Authors:  Lukas Fenner; Bijaya Malla; Béatrice Ninet; Olivier Dubuis; David Stucki; Sonia Borrell; Thembela Huna; Thomas Bodmer; Matthias Egger; Sebastien Gagneux
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

10.  Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology.

Authors:  Karine Brudey; Jeffrey R Driscoll; Leen Rigouts; Wolfgang M Prodinger; Andrea Gori; Sahal A Al-Hajoj; Caroline Allix; Liselotte Aristimuño; Jyoti Arora; Viesturs Baumanis; Lothar Binder; Patricia Cafrune; Angel Cataldi; Soonfatt Cheong; Roland Diel; Christopher Ellermeier; Jason T Evans; Maryse Fauville-Dufaux; Séverine Ferdinand; Dario Garcia de Viedma; Carlo Garzelli; Lidia Gazzola; Harrison M Gomes; M Cristina Guttierez; Peter M Hawkey; Paul D van Helden; Gurujaj V Kadival; Barry N Kreiswirth; Kristin Kremer; Milan Kubin; Savita P Kulkarni; Benjamin Liens; Troels Lillebaek; Minh Ly Ho; Carlos Martin; Christian Martin; Igor Mokrousov; Olga Narvskaïa; Yun Fong Ngeow; Ludmilla Naumann; Stefan Niemann; Ida Parwati; Zeaur Rahim; Voahangy Rasolofo-Razanamparany; Tiana Rasolonavalona; M Lucia Rossetti; Sabine Rüsch-Gerdes; Anna Sajduda; Sofia Samper; Igor G Shemyakin; Urvashi B Singh; Akos Somoskovi; Robin A Skuce; Dick van Soolingen; Elisabeth M Streicher; Philip N Suffys; Enrico Tortoli; Tatjana Tracevska; Véronique Vincent; Tommie C Victor; Robin M Warren; Sook Fan Yap; Khadiza Zaman; Françoise Portaels; Nalin Rastogi; Christophe Sola
Journal:  BMC Microbiol       Date:  2006-03-06       Impact factor: 3.605

View more
  110 in total

1.  Phylogenetic Analysis of Mycobacterium tuberculosis Strains in Wales by Use of Core Genome Multilocus Sequence Typing To Analyze Whole-Genome Sequencing Data.

Authors:  R C Jones; L G Harris; S Morgan; M C Ruddy; M Perry; R Williams; T Humphrey; M Temple; A P Davies
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

Review 2.  Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.

Authors:  N P Mnyambwa; D-J Kim; E S Ngadaya; R Kazwala; P Petrucka; S G Mfinanga
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-07       Impact factor: 3.267

Review 3.  Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

Authors:  Paul K Drain; Kristina L Bajema; David Dowdy; Keertan Dheda; Kogieleum Naidoo; Samuel G Schumacher; Shuyi Ma; Erin Meermeier; David M Lewinsohn; David R Sherman
Journal:  Clin Microbiol Rev       Date:  2018-07-18       Impact factor: 26.132

4.  Molecular typing of mycobacteria isolated from tuberculous lymphadenitis cases in Addis Ababa, Ethiopia.

Authors:  O Zewdie; A Mihret; G Ameni; A Worku; T Gemechu; T Abebe
Journal:  Int J Tuberc Lung Dis       Date:  2016-11       Impact factor: 2.373

5.  Molecular epidemiology of M. tuberculosis in Ethiopia: A systematic review and meta-analysis.

Authors:  Daniel Mekonnen; Awoke Derbie; Asmamaw Chanie; Abebe Shumet; Fantahun Biadglegne; Yonas Kassahun; Kidist Bobosha; Adane Mihret; Liya Wassie; Abaineh Munshea; Endalkachew Nibret; Solomon Abebe Yimer; Tone Tønjum; Abraham Aseffa
Journal:  Tuberculosis (Edinb)       Date:  2019-08-07       Impact factor: 3.131

6.  Mycobacterium tuberculosis lineage 7 strains are associated with prolonged patient delay in seeking treatment for pulmonary tuberculosis in Amhara Region, Ethiopia.

Authors:  Solomon A Yimer; Gunnstein Norheim; Amine Namouchi; Ephrem D Zegeye; Wibeke Kinander; Tone Tønjum; Shiferaw Bekele; Turid Mannsåker; Gunnar Bjune; Abraham Aseffa; Carol Holm-Hansen
Journal:  J Clin Microbiol       Date:  2015-02-11       Impact factor: 5.948

7.  Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devices.

Authors:  Michel Kiréopori Gomgnimbou; Iván Hernández-Neuta; Stefan Panaiotov; Elizabeta Bachiyska; Juan Carlos Palomino; Anandi Martin; Patricia del Portillo; Guislaine Refregier; Christophe Sola
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

8.  Diversity of Mycobacterium tuberculosis across Evolutionary Scales.

Authors:  Mary B O'Neill; Tatum D Mortimer; Caitlin S Pepperell
Journal:  PLoS Pathog       Date:  2015-11-12       Impact factor: 6.823

Review 9.  Circulation of M. tuberculosis Beijing genotype in Latin America and the Caribbean.

Authors:  M I Cerezo-Cortés; J G Rodríguez-Castillo; R Hernández-Pando; M I Murcia
Journal:  Pathog Glob Health       Date:  2020-01-05       Impact factor: 2.894

Review 10.  Genomic insights into tuberculosis.

Authors:  James E Galagan
Journal:  Nat Rev Genet       Date:  2014-03-25       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.